Keytruda, manufactured by the US-based Merck & Co, is an immunotherapy drug that has become one of the world’s best-selling drugs. It is being used to treat several cancers, including those in the lung, breast and skin. However, the life-saving drug remains out of bounds for several thousand cancer patients in India, as it is priced over Rs 1.5 lakh for a 100 mg vial
firstpost.com
